The European Medicines Agency (EMA) has begun reviewing the Pfizer vaccine for children aged five to eleven. The American-German vaccine maker Pfizer/BioNTech had submitted a request for this on Friday.
EMA assesses whether Pfizer is also suitable for five to eleven-year-olds
:quality(85)//cloudfront-us-east-1.images.arcpublishing.com/infobae/XNMO6VT5WJE3NMENLOS3QOV6RE.jpg)
